157 related articles for article (PubMed ID: 1921896)
1. [Hemodynamic effects of intermittent intra-arterial infusion treatment with prostaglandin E1 in peripheral arterial occlusive disease].
Ranke C; Creutzig A; Alexander K
Med Klin (Munich); 1991 Jul; 86(7):349-52, 382. PubMed ID: 1921896
[TBL] [Abstract][Full Text] [Related]
2. [The temporal course of hemodynamic changes following intermittent intra-arterial infusion therapy: follow-up based on duplex sonographic parameters].
Ranke C; Creutzig A; Alexander K
Vasa Suppl; 1991; 32():383-5. PubMed ID: 1771540
[No Abstract] [Full Text] [Related]
3. [Duplex ultrasound measurement of morphologic parameters before and following repeated puncture of the femoral artery for intermittent infusion therapy].
Ranke C; Creutzig A; Alexander K
Vasa; 1990; 19(3):203-6. PubMed ID: 2238813
[TBL] [Abstract][Full Text] [Related]
4. [Duplex ultrasound measurement of hemodynamic parameters at rest and following arterial stenosis: effect of intra-arterial infusion therapy with prostaglandin E1].
Ranke C; Creutzig A; Alexander K
Vasa Suppl; 1989; 27():353-5. PubMed ID: 2696104
[No Abstract] [Full Text] [Related]
5. [Intravenous administration of PGE1: studies of the effectiveness and duration of the effect of various dosages based on flow measurements of the femoral artery in patients with healthy vessels and in stage IIb arterial occlusive disease].
Scheffler P; Birkel L; Grub KR; de la Hamette D
Vasa Suppl; 1988; 23():126-9. PubMed ID: 3061035
[No Abstract] [Full Text] [Related]
6. [Intravenous and intra-arterial prostaglandin E1 treatment in patients with stage IIb arterial occlusive disease].
Rudofsky G
Vasa Suppl; 1988; 23():121-5. PubMed ID: 3206330
[No Abstract] [Full Text] [Related]
7. Neutrophil function in peripheral arterial occlusive disease: the effects of prostaglandin E1.
Weiss T; Eckstein H; Weiss C; Diehm C
Vasc Med; 1998; 3(3):171-5. PubMed ID: 9892509
[TBL] [Abstract][Full Text] [Related]
8. [Intra-arterial administration of prostaglandin E1 in occlusive arterial diseases].
Davidović L; Vranes M; Cernak I; Kostić D; Lovrić A; Sagić D; Lotina S
Srp Arh Celok Lek; 1992; 120(1-2):9-14. PubMed ID: 1641706
[TBL] [Abstract][Full Text] [Related]
9. [Placebo controlled study of the effect of intravenous PGE1 on macro- and microcirculation in patients with stage III/IV arterial occlusive disease].
Scheffler P; de la Hamette D; Leipnitz G
Vasa Suppl; 1991; 33():343-4. PubMed ID: 1788750
[TBL] [Abstract][Full Text] [Related]
10. Intraarterial perfusion of prostaglandin E1 after lumbar sympathectomy or reconstruction on femoropopliteal segment.
Davidovic LB; Vranes MR; Lotina SI; Cernak IF; Velimirovic DB; Stojanov PL; Sindjelic RP; Sagic DZ; Cinara IS
Int Angiol; 1991; 10(3):178-81. PubMed ID: 1765722
[TBL] [Abstract][Full Text] [Related]
11. Trial of a novel prostacyclin analog, UT-15, in patients with severe intermittent claudication.
Mohler ER; Klugherz B; Goldman R; Kimmel SE; Wade M; Sehgal CM
Vasc Med; 2000; 5(4):231-7. PubMed ID: 11213235
[TBL] [Abstract][Full Text] [Related]
12. Effects of intra-arterial prostaglandin E1 in patients with peripheral arterial occlusive disease.
Creutzig A; Creutzig H; Alexander K
Eur J Clin Invest; 1986 Dec; 16(6):480-5. PubMed ID: 3104047
[TBL] [Abstract][Full Text] [Related]
13. Skin oxygen pressure histograms in patients with peripheral arterial occlusive disease during intraarterial and intravenous prostaglandin E1 infusions of different dosages and their prognostic value.
Creutzig A; Arnold A; Caspary L; Thum J; Alexander K
Angiology; 1995 May; 46(5):357-67. PubMed ID: 7741319
[TBL] [Abstract][Full Text] [Related]
14. [Effect of intra-arterial and intravenous PGE1 infusions on transcutaneous oxygen pressure in patients with critical ischemia of the extremities].
Weiss T; Griesshaber J; Rogatti W; Kistner O; Hsu E; Jansen T; Diehm C
Vasa Suppl; 1991; 33():341-2. PubMed ID: 1788749
[TBL] [Abstract][Full Text] [Related]
15. [Prostaglandin E1 in intermittent claudication].
Scheffler P; de la Hamette D; Rogatti W
Vasa Suppl; 1992; 35():147-8. PubMed ID: 1481022
[No Abstract] [Full Text] [Related]
16. Effects of intravenous prostaglandin E1 on arterial compliance: a randomized controlled trial.
Mlekusch W; Schillinger M; Sabeti S; Al-Awami M; Gschwandtner M; Minar E
Vasa; 2004 Aug; 33(3):131-6. PubMed ID: 15461064
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic effects of intravenous PGE1 on patients with arterial occlusive disease of the leg.
Hirai M; Nanki M; Nakayama R
Angiology; 1985 Jul; 36(7):407-13. PubMed ID: 4040721
[TBL] [Abstract][Full Text] [Related]
18. [Quantitative flow measurement of the art. dorsalis pedis in normal probands and patients with arterial occlusive disease of a low Fontaine stage].
Francesconi M; Pokorny E
Vasa Suppl; 1991; 33():314-5. PubMed ID: 1788732
[TBL] [Abstract][Full Text] [Related]
19. Effect of prostaglandin E1 upon collateral vessels in peripheral occlusive arterial disease.
Rudofsky G; Gerngross U
Prog Clin Biol Res; 1989; 301():407-9. PubMed ID: 2798455
[No Abstract] [Full Text] [Related]
20. [Noninvasive studies of macro- and microcirculation in follow-up of femoropopliteal bypass operation in IIb peripheral arterial occlusive disease].
Scheffler P; Gross J; Dabringhaus S; de la Hamette D; Walter P
Vasa; 1994; 23(4):312-20. PubMed ID: 7817611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
